Credit Suisse’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12
| Closed | – | – | 4279 |
|
|
2022
Q2 | $0 | Sell |
12
-15,189
| -100% | – | ﹤0.01% | 4303 |
|
|
2022
Q1 | $99K | Buy |
15,201
+445
| +3% | +$2.9K | ﹤0.01% | 3458 |
|
|
2021
Q4 | $172K | Buy |
14,756
+1,304
| +10% | +$15.2K | ﹤0.01% | 3472 |
|
|
2021
Q3 | $249K | Buy |
13,452
+63
| +0.5% | +$1.17K | ﹤0.01% | 3314 |
|
|
2021
Q2 | $283K | Buy |
+13,389
| New | +$283K | ﹤0.01% | 3300 |
|